Measuring Smoking Behaviors While Using Varenicline
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This study will demonstrate the behavioral responses to varenicline, helping to better
understand its mechanisms. Hypotheses for the study are to observe decreases in smoking
topography and nicotine cigarette choice on varenicline, relative to placebo; and decreases
on day 21 relative to day 7 during varenicline treatment. We also propose to examine if
extended duration of treatment has clinical significance in decreasing smoking behaviors,
thus increasing the efficacy of varenicline.